Introduction
Juxtaposition of the BCL2 gene to the IGH locus is a result of the t(14;18)(q32;q21) and is observed in more than 90% of follicular lymphomas (FLs). 1 The composition of the breakpoints indicate an origin from aberrant RAG1/RAG2-mediated VDJ recombination. 2 Most breakpoints are located in the major and minor breakpoint regions (MBRs and mcrs) 3Ј of BCL2. In consequence, BCL2 is deregulated by juxtaposition to the centromeric part of the IGH complex containing the IGH enhancers. In contrast, 5ЈBCL2 breakpoints commonly show juxtaposition to immunoglobulin light chain loci. 3, 4 Using DNA-fiber fluorescent in situ hybridization (FISH), we recently described the configuration of t(14;18) breakpoints in 40 FLs, including 2 cases with a double 5Ј and 3Ј breakpoint and insertion in the IGH locus. 5 One other lymphoma contained a single 5ЈBCL2 breakpoint joined to IGH sequences. 3 In this paper, we describe this breakpoint in detail. DNA and RNA analysis revealed genomic breakpoints at IGH-S and BCL2 intron 1 and expression of a chimeric I -BCL2 fusion product. Furthermore, we investigated the nontranslocated, functional IGH allele to find out whether the tumor cells were still able to undergo hypermutations in the V H region. These data indicate that in sporadic but otherwise classical FL, the t(14;18), and in consequence the BCL2 activation, can occur as a late event during germinal center B-cell development.
Study design
Both FL samples (FL5094 and FL10444) were classified according to the Revised European-American classification of Lymphoid Neoplasms. 6 Immunophenotyping and fiber FISH have been previously described. 3 Polymerase chain reaction (PCR) and reverse-transcriptase PCR (RT-PCR) were performed under standard conditions; the sequences of the primers are described in the figure legends. PCR products were cloned, sequenced, and analyzed as previously described. 7 IGH V H gene hypermutations were analyzed according to Aarts et al. 8 
Results and discussion
The original inguinal lymph node biopsy (FL5094) from a woman age 71 years taken in 1996, showed a CD20, CD79a, CD10, BCL2, and BCL6 protein positive follicle center cell lymphoma 6 with a partially follicular growth pattern, grade 1 according to the Berard system. 9 Interfollicular plasmacytoid cells weakly expressed IgA. Clinical staging revealed stage I. A relapse (FL10444) in 1997 showed a completely diffuse follicle center cell lymphoma, grade 1. The patient was treated with chlorambucil and died in 1999 because of sepsis.
Fiber FISH analysis of FL5094 with IGH and BCL2 probes identified a 5ЈBCL2 breakpoint. Both derivatives, the putative der (14) and der (18) , were visualized, suggesting a reciprocal translocation. 3 The BCL2 and IGH genes were in the same orientation as seen in regular FL with a 3Ј MBR/mcr BCL2 breakpoint. In consequence, the IGH constant-region genes (C H ) were not juxtaposed to the BCL2 gene but rather to its derivative 5Ј flanking region. To investigate the position of the E enhancer, additional fiber FISH with a PCR-generated E probe was performed. This revealed juxtaposition of E to the 5Ј side of BCL2, suggesting a breakpoint at S . The der(14) consisted of a large 5Ј part and probably also the first (noncoding) exon of BCL2 and a part of the IGH C H locus, suggesting a class-switch event with deletion of some C H genes. To confirm an S /BCL2 fusion at der (18) , PCR was performed with primers for the region 5Ј of S and for the first intron of BCL2 ( Figure 1A ). Sequence analysis of this 500-base pair (bp) patient-specific product showed a BCL2 breakpoint in intron 1 and an IGH breakpoint 5Ј of S ( Figure 1B ). This part of S is commonly used in normal switch recombination events 10 and in t(8;14) translocations with a breakpoint at S /MYC in Burkitt lymphoma. 11 Very likely, and similarly to FL with a regular t(14;18), the observed juxtaposition of E to the 5ЈBCL2 region resulted in deregulation of BCL2. However, the observed configuration might also have led to the formation of a chimeric IGH-BCL2 transcript starting from the transcription initiation site I . Therefore, we performed RT-PCR with primers for the region immediately 3Ј of I and exon 3 of BCL2 (Figure 2A ). Sequence analysis of the 5Ј end of this product of approximately 1 kilobase (kb) revealed 78 bp of the I sequence directly followed by the 5Ј nontranslated region of the second exon of BCL2 ( Figure 2B ). Thus, splicing events at regular splice acceptor and donor sites removed most of the S region and all BCL2 intronic sequences. In addition, there was normal splicing of the second intron of BCL2. 12 Of note, the first exon is untranslated, and in consequence a breakpoint in the first intron will not lead to structural abnormalities of the BCL2 protein. 
org From
Our data show transcription over the translocation breakpoint into exons 2 and 3 of BCL2, suggesting transcription from I or more upstream promoters. 12 Interestingly, I is implicated in germline transcription necessary for class switching in normal B cells. 13 In our case, such germline transcription may have preceded an illegitimate class-switch event at S leading to this particular translocation.
Normal B cells undergo a series of gene recombinations starting with RAG1/RAG2-mediated V(D)J rearrangements of the IGH and immunoglobulin light chain genes in bone marrow precursor B cells, followed by somatic hypermutations in the early phase and immunoglobulin gene class-switch recombinations in a later phase of the follicle center cell reaction. 14, 15 In all FLs analyzed so far, t(14;18) breakpoint sequences point to a RAG1/RAG2-mediated illegitimate recombination at J H or D H sites. Furthermore, although this has been debated since the observations that RAG1/RAG2 can be expressed in mature B cells, [16] [17] [18] [19] [20] both the presence of N-regions and the occasional occurrence of a terminal transferase positive blast crisis 21 support the origin from precursor B cells. Thus, the t(14;18) in FL is considered to occur in precursor B cells while the tumor cells undergo modifications, including somatic hypermutations of the functional IGH genes, much later, when they have entered the follicle center cell compartment. To our knowledge, the present case is the first FL with an IGH-BCL2 breakpoint within a switch site. 14, 15 We also did not identify in the literature any t(14;18) breakpoint that might have originated from aberrant somatic hypermutation. Thus, although we cannot formally exclude that this particular class switching-mediated translocation had occurred in a precursor B cell, 22 the configuration supports a late origin during the follicle center cell reaction. Translocations involving IGH switch regions (or sites of hypermutations) are by contrast regularly found in sporadic Burkitt lymphoma, 11 myeloma, 23 and diffuse large cell lymphoma. 24 To study other aspects of B-cell maturation that might shed light on the ontogeny of this lymphoma, we investigated possible somatic mutations on its functional IGH allele. Using V H familyspecific primers, V H 4/C ␣ transcripts were amplified by RT-PCR from both tumor samples. Sequence analyses of the crude RT-PCR products as well as, respectively, 15 and 8 subclones, showed the highest homology to V4-34. In comparison with this gene segment, the individual clones of both biopsies showed 40 and 39 shared mutations, respectively, indicating clonal expansion from an already heavily mutated B cell. In addition, the 15 clones of the first biopsy contained 53 nonshared mutations (intraclonal variation, 3.5 mutations per clone) corroborating the "ongoing mutations" as seen in normal FL. 8 The follow-up biopsy showed a much lower intraclonal variation of fewer than 0.4 mutations per clone, which was most likely due to a selective outgrowth of tumor cells. 8 Thus, we propose that in this particular FL, a normal mature B cell acquired the t(14;18) during IGH class switching. Just like normal FL cells, its daughter cells could re-enter the follicle center cell reaction elsewhere in the lymphoid tissues where they underwent additional rounds of somatic mutations in the functional IGH allele.
